Thrombolytics and Myocardial Infarction-Reference-Cited by-同舟云学术

Thrombolytics and Myocardial Infarction

Published:2010-11-11 Issue:2 Volume:30 Page:e81-e88
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:

Author:

Kunadian Vijayalakshmi,Gibson C. Michael

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2010.00239.x/fullpdf

Reference70 articles.

1. 2009

2. Coronary obstruction;Kerrick;JAMA,1912

3. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy;Fletcher;Trans Assoc Am Physicians,1958

4. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials;Yusuf;Eur Heart J,1985

5. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase;Koren;N Engl J Med,1985

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytoconstituents with cardioprotective properties: A pharmacological overview on their efficacy against myocardial infarction;Phytotherapy Research;2024-07-18

2. Maggot Kinase and Natural Thrombolytic Proteins;ACS Omega;2024-05-02

3. Sepsis and antibiotics: When should we deploy a parachute?;International Journal of Antimicrobial Agents;2023-04

4. Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options?;International Journal of Molecular Sciences;2022-09-07

5. Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects;Materials Today Bio;2022-03